Laporan Laba Rugi (TTM)
Laporan Laba Rugi JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. - Equity Right menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 463 | 433 | 421 | 422 | 429 | 419 | 419 | 419 | 467 | 506 | 518 | 585 | 594 | 628 | 703 | 769 | 846 | 918 | 984 |
Change (%) | -6.44 | -2.72 | 0.29 | 1.59 | -2.40 | -0.05 | 0.12 | 11.37 | 8.31 | 2.53 | 12.94 | 1.53 | 5.62 | 11.91 | 9.47 | 10.00 | 8.57 | 7.17 | |
% of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
Cost Of Sales | 310 | 285 | 273 | 274 | 278 | 277 | 284 | 286 | 313 | 340 | 361 | 417 | 432 | 458 | 484 | 491 | 519 | 545 | 570 |
Change (%) | -8.11 | -4.19 | 0.48 | 1.37 | -0.24 | 2.23 | 0.80 | 9.57 | 8.48 | 6.42 | 15.48 | 3.50 | 5.96 | 5.83 | 1.40 | 5.75 | 4.97 | 4.45 | |
% of Revenue | 67.00 | 65.80 | 64.80 | 64.92 | 64.78 | 66.21 | 67.72 | 68.18 | 67.08 | 67.18 | 69.74 | 71.31 | 72.69 | 72.93 | 68.96 | 63.88 | 61.41 | 59.37 | 57.87 |
Gross Operating Profit | 153 | 148 | 148 | 148 | 151 | 142 | 135 | 133 | 154 | 166 | 157 | 168 | 162 | 170 | 218 | 278 | 326 | 373 | 415 |
Change (%) | -3.05 | 0.12 | -0.04 | 2.00 | -6.37 | -4.51 | -1.31 | 15.23 | 7.95 | -5.45 | 7.08 | -3.37 | 4.71 | 28.30 | 27.40 | 17.51 | 14.30 | 11.14 | |
% of Revenue | 33.00 | 34.20 | 35.20 | 35.08 | 35.22 | 33.79 | 32.28 | 31.82 | 32.92 | 32.82 | 30.26 | 28.69 | 27.31 | 27.07 | 31.04 | 36.12 | 38.59 | 40.63 | 42.13 |
SG&A | 100 | 98 | 95 | 96 | 103 | 118 | 135 | 149 | 155 | 154 | 152 | 155 | 163 | 170 | 180 | 197 | 224 | 257 | 282 |
Change (%) | -1.70 | -2.76 | 0.35 | 7.64 | 14.52 | 14.50 | 10.57 | 3.78 | -0.65 | -0.97 | 1.81 | 4.96 | 4.51 | 6.09 | 9.03 | 13.93 | 14.74 | 9.75 | |
% of Revenue | 21.53 | 22.62 | 22.61 | 22.62 | 23.97 | 28.12 | 32.22 | 35.58 | 33.15 | 30.41 | 29.38 | 26.48 | 27.38 | 27.09 | 25.68 | 25.58 | 26.49 | 28.00 | 28.67 |
R&D | |||||||||||||||||||
Change (%) | |||||||||||||||||||
% of Revenue | |||||||||||||||||||
OpEx | 410 | 383 | 368 | 370 | 381 | 395 | 418 | 435 | 468 | 493 | 514 | 572 | 595 | 628 | 665 | 688 | 744 | 802 | 852 |
Change (%) | -6.55 | -3.83 | 0.44 | 2.99 | 3.75 | 5.89 | 3.95 | 7.59 | 5.46 | 4.12 | 11.43 | 3.89 | 5.56 | 5.90 | 3.47 | 8.09 | 7.91 | 6.15 | |
% of Revenue | 88.52 | 88.42 | 87.41 | 87.54 | 88.75 | 94.33 | 99.93 | 103.76 | 100.23 | 97.60 | 99.11 | 97.79 | 100.07 | 100.02 | 94.64 | 89.45 | 87.90 | 87.37 | 86.54 |
Operating Income | 53 | 50 | 53 | 53 | 48 | 24 | 0 | -16 | -1 | 12 | 5 | 13 | -0 | -0 | 38 | 81 | 102 | 116 | 133 |
Change (%) | -5.58 | 5.75 | -0.75 | -8.24 | -50.85 | -98.83 | -5,791.67 | -93.18 | -1,231.25 | -62.21 | 181.79 | -103.15 | -75.23 | -37,340.36 | 115.43 | 26.20 | 13.34 | 14.22 | |
% of Revenue | 11.48 | 11.58 | 12.59 | 12.46 | 11.25 | 5.67 | 0.07 | -3.76 | -0.23 | 2.40 | 0.89 | 2.21 | -0.07 | -0.02 | 5.36 | 10.55 | 12.10 | 12.63 | 13.46 |
Interest Expense | -11 | -11 | -10 | -11 | -10 | -10 | -10 | -9 | -9 | -10 | -10 | -12 | -13 | -15 | -16 | -17 | -17 | -16 | -16 |
Change (%) | -3.99 | -5.44 | 1.35 | -1.20 | -6.41 | 4.78 | -7.02 | -3.11 | 7.80 | 2.54 | 13.73 | 12.50 | 12.62 | 8.34 | 5.01 | -0.50 | -0.79 | -5.49 | |
% of Revenue | -2.47 | -2.54 | -2.47 | -2.49 | -2.42 | -2.32 | -2.44 | -2.26 | -1.97 | -1.96 | -1.96 | -1.97 | -2.19 | -2.33 | -2.26 | -2.17 | -1.96 | -1.79 | -1.58 |
Net Income | 31 | 29 | 32 | 32 | 30 | 11 | -13 | -24 | -17 | -4 | -6 | 2 | -2 | -6 | 22 | 51 | 5 | 14 | 28 |
Change (%) | -5.87 | 8.84 | 0.64 | -7.36 | -64.19 | -223.31 | 84.14 | -27.58 | -76.88 | 37.53 | -144.80 | -169.04 | 251.51 | -455.85 | 137.92 | -91.16 | 220.04 | 96.34 | |
% of Revenue | 6.72 | 6.76 | 7.56 | 7.59 | 6.92 | 2.54 | -3.13 | -5.76 | -3.75 | -0.80 | -1.07 | 0.43 | -0.29 | -0.96 | 3.06 | 6.65 | 0.53 | 1.58 | 2.89 |
Source: Capital IQ